Casey Albin, MD
Casey Albin, MD

@caseyalbin

14 Tweets 10 reads Jun 14, 2023
1/ #ContinuumCase!!
A 50 yo man presented to the ED with acute onset aphasia. He is not able to report a history, but BP Is 215/95.
Non-contrast HCT reveals this bleed…
What do you want to see next?
2/
What do you most want next?
3/
Cortical bleeds are IMHO way more fun than basal ganglia hemorrhages.
Even though BP was elevated, that is true of many patients who have non-hypertensive etiologies of their bleeds!
In these patients you must consider:
🩸CAA
🩸Endocarditis
🩸Atypical aneurysms
🩸RCVS....
4/
And ... Venous Sinus Thrombosis!
In this case, even just a closer review of the non-con provides a very important clue.
A cord sign! A hyperdense signal within a venous sinus (in this case transverse / sigmoid sinus)
5/
Note that there are numerous venous variants, but the two important cortical veins to remember are the Vein of Trolard (top) drains to saggital sinus; and Vein of Labbe (low) drains to transverse sinus.
6/
Intracerebral hemorrhage is present in 1/3 of patients.
But you should think of CVT if the IPH is:
➡️Multiple
➡️Ill-defined w/ surrounding edema
➡️Non-arterial territories
➡️ Involve bilateral basal ganglia or thalami
➡️ Cortical
7/
While both CTV and MRV with contrast (NOT TOF MRV, poor resolution, proned to artifacts) offer high sensitivity for CVT detection, contrasted MRI can better demonstrate the parenchymal changes.
8/
You may even find a brush sign on paramagnetic-sensitive MRI sequences, particularly if there is a deep CVT!
9/
In this case, both CTV and MRV demonstrated thrombus within the transverse sinus, sigmoid sinus, IJ, and vein of Labbe.
10/
A thoughtful approach to laboratory testing and further workup is detailed in the @continuumaan article, which you should check out!
But let’s skip to treatment. Whats your next move:
11/
While there is mounting evidence for the safety of efficacy of DOACs in CVT, guildelines recommend starting with a parenteral anticoagulant.
The ESO guidelines have a weak recommendation for LMWH > heparin for a non-sig trend towards 🔼 functional outcomes & 🔽 mortality.
12/
With unfractionated heparin, the goal should be to have the drug in the therapeutic range quickly, even if ICH Is present.
13/
For patients who worsen despite medical treatment, EVT is an option although the exact efficacy is still debated.
TO-ACT, a trial of endovascular therapy, has been difficult to interpret due to a small sample size.
14/
For an incredible discussion about this fascinating and rare form of stroke, check out Dr Liberman’s (@ava_liberman) review, which is available in the latest issue of @continuumAAN
journals.lww.com

Loading suggestions...